Ackermans & van Haaren

ACKERMANS: PATIENCE IS THE NEW ALPHA (ADD; 23%)

23/10/25 -" Risk is fashionable again, and HoldCos have joined the party. Since April, investors have rediscovered their appetite for leverage and structure. Discounts to NAV are still wide, hovering around ..."

PDF page sample
Pages
65
Language
English
Published on
23/10/25
Download
You may also be interested by these reports :
24/10/25
We have decided to write down the Stegra stake value from SEK 1,280m to 0 following press reports (FT among others) of important financing issues ...
24/10/25
Wendel’s Q3 felt more like a strategy memo than a quarterly report. The group keeps morphing into a fully-fledged asset manager. After bringing in IK ...
23/10/25
Bolloré reported very poor Q3 figures on its remaining operational assets. The group continued to buy back its shares (without disclosing the ...
23/10/25
We have incorporated the goodwill impairment of c.€4.1bn recorded in H1-25 into our model, which has consequently impacted our EPS forecast for the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO